187 related articles for article (PubMed ID: 28117882)
1. Treatment-associated toxicities reported by patients with early-stage invasive breast cancer.
Friese CR; Harrison JM; Janz NK; Jagsi R; Morrow M; Li Y; Hamilton AS; Ward KC; Kurian AW; Katz SJ; Hofer TP
Cancer; 2017 Jun; 123(11):1925-1934. PubMed ID: 28117882
[TBL] [Abstract][Full Text] [Related]
2. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
3. Symptoms after breast cancer treatment: are they influenced by patient characteristics?
Yoon J; Malin JL; Tao ML; Tisnado DM; Adams JL; Timmer MJ; Ganz PA; Kahn KL
Breast Cancer Res Treat; 2008 Mar; 108(2):153-65. PubMed ID: 17492377
[TBL] [Abstract][Full Text] [Related]
4. Toxicity-Related Factors Associated With Use of Services Among Community Oncology Patients.
Harrison JM; Stella PJ; LaVasseur B; Adams PT; Swafford L; Lewis J; Mendelsohn-Victor K; Friese CR
J Oncol Pract; 2016 Aug; 12(8):e818-27. PubMed ID: 27407166
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
[TBL] [Abstract][Full Text] [Related]
6. Treatment decisions and employment of breast cancer patients: Results of a population-based survey.
Jagsi R; Abrahamse PH; Lee KL; Wallner LP; Janz NK; Hamilton AS; Ward KC; Morrow M; Kurian AW; Friese CR; Hawley ST; Katz SJ
Cancer; 2017 Dec; 123(24):4791-4799. PubMed ID: 28990155
[TBL] [Abstract][Full Text] [Related]
7. The advantages of hypnosis intervention on breast cancer surgery and adjuvant therapy.
Berlière M; Roelants F; Watremez C; Docquier MA; Piette N; Lamerant S; Megevand V; Van Maanen A; Piette P; Gerday A; Duhoux FP
Breast; 2018 Feb; 37():114-118. PubMed ID: 29136523
[TBL] [Abstract][Full Text] [Related]
8. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
9. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
[TBL] [Abstract][Full Text] [Related]
10. Treatment experiences of Latinas after diagnosis of breast cancer.
Katz SJ; Wallner LP; Abrahamse PH; Janz NK; Martinez KA; Shumway DA; Hamilton AS; Ward KC; Resnicow KA; Hawley ST
Cancer; 2017 Aug; 123(16):3022-3030. PubMed ID: 28398629
[TBL] [Abstract][Full Text] [Related]
11. Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women.
Prehn AW; Topol B; Stewart S; Glaser SL; O'Connor L; West DW
Cancer; 2002 Dec; 95(11):2268-75. PubMed ID: 12436431
[TBL] [Abstract][Full Text] [Related]
12. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
13. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after mastectomy with immediate breast reconstruction for breast cancer in a multiethnic, middle-income Asian setting.
See MH; Sinnadurai S; Lai LL; Tan KL; Teh MS; Teoh LY; Jamaris S; Abdul Malik R; Bhoo-Pathy N
Surgery; 2021 Dec; 170(6):1604-1609. PubMed ID: 34538341
[TBL] [Abstract][Full Text] [Related]
15. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Haviland JS; Owen JR; Dewar JA; Agrawal RK; Barrett J; Barrett-Lee PJ; Dobbs HJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Simmons S; Sydenham MA; Venables K; Bliss JM; Yarnold JR;
Lancet Oncol; 2013 Oct; 14(11):1086-1094. PubMed ID: 24055415
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program.
Rana S; Naik A; Pillai S; Vetto J; Pommier R; Kubicky CD
Am J Surg; 2020 Apr; 219(4):655-659. PubMed ID: 31242962
[TBL] [Abstract][Full Text] [Related]
17. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.
Zork NM; Komenaka IK; Pennington RE; Bowling MW; Norton LE; Clare SE; Goulet RJ
Ann Surg; 2008 Aug; 248(2):280-5. PubMed ID: 18650639
[TBL] [Abstract][Full Text] [Related]
18. T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.
Perrucci E; Aristei C; De Angelis V; Anselmo P; Mascioni F; Gori S; Frattegiani A; Latini P
Tumori; 2004; 90(4):379-86. PubMed ID: 15510979
[TBL] [Abstract][Full Text] [Related]
19. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer.
Gilcrease MZ; Woodward WA; Nicolas MM; Corley LJ; Fuller GN; Esteva FJ; Tucker SL; Buchholz TA
Am J Surg Pathol; 2009 May; 33(5):759-67. PubMed ID: 19252432
[TBL] [Abstract][Full Text] [Related]
20. Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
Adachi Y; Okumura S; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Sugino K; Horisawa N; Ozaki Y; Endo Y; Sakamoto S; Iwata H
Breast Cancer; 2020 Jul; 27(4):716-723. PubMed ID: 32162180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
